Mainz Biomed
In Brief This Week: Ultima Genomics, Scale Bio, Mainz Biomed, Eurofins, Synlab, GenomeDE, More
News items for the week of March 31, 2025.
Mainz Biomed Launches Study for Colon Cancer Screening Test, Aiming for Added Sensitivity
The firm already markets the assay in Europe, but is planning to begin another study to support adoption in the US, if its current trial is successful.
Mainz Biomed, Liquid Biosciences Partner on Pancreatic Cancer Test
Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.
In Brief This Week: Guardant Health, Genetic Signatures, Mainz Biomed, Devyser, Akoya, More
News items for the week of Jan. 27, 2025.
Quest Diagnostics Enters Agreement to Provide Clinical Trial Lab Services for Mainz Biomed
Quest will provide clinical trial services for Mainz's Biomed's clinical study for its ColoAlert colorectal cancer test. Quest also will have the option to provide testing services.